Results 121 to 130 of about 9,366 (178)

Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy. [PDF]

open access: yesEur J Neurol
Furukawa S   +12 more
europepmc   +1 more source

Chronic Inflammatory Demyelinating Polyneuropathy

New England Journal of Medicine, 2005
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated disease of the peripheral nervous system with a prevalence of 1-2/100,000. Clinical and experimental findings suggest a role of immune pathomechanisms;however, the target antigens are still unknown.
Hans-Peter Hartung   +2 more
exaly   +4 more sources

Treatment of chronic inflammatory demyelinating polyneuropathy

Muscle & Nerve, 2022
AbstractChronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic peripheral polyneuropathy that results in disability through immune‐mediated nerve injury, but which not uncommonly has residual and irreversible neurological deficits after the active inflammatory component of the disorder has been treated.
Jeffrey A. Allen, Richard A. Lewis
openaire   +2 more sources

Home - About - Disclaimer - Privacy